Neurontin

Neurontin (gabapentin) was approved by the Food and Drug Administration (FDA) in 1994 for the control of partial seizures due to epilepsy in adults and children. It is also approved for management of postherpetic neuralgia (PHN) caused by shingles (herpes zoster). Neurontin affects chemicals and nerves in the body that are involved in the cause of seizures and certain types of pain. The exact way it works is unknown.

Neurontin was originally sold by Parke-Davis, a subsidiary of Warner-Lambert, which in turn was acquired by Pfizer, Inc., in 2000. It has been uncovered that the makers of Neurontin, have paid thousands of dollars to doctors for prescribing the drug for illnesses unrelated to its original, FDA-approved purpose including bipolar disorder, ADD, migraines, neuralgia, neuropathy, restless leg syndrome, and drug and alcohol withdrawal seizures In spite of concerns for patient health and medical ethics, the drug makers devised a reckless, profit-making scheme designed to access the drug to a wider market.

Neurontin has been associated with suicides, suicidal thoughts, suicidal ideation, hostility, paranoia and anxiety.

If you or a loved one is in need of legal assistance, call Adel & Pollack at (310) 443-4455 or submit an online questionnaire. The initial consultation is free of charge, and if we agree to handle your case, in most cases we will work on a contingency fee basis, which means we get paid for our services only if there is a monetary recovery of funds. In many cases, a lawsuit must be filed before an applicable expiration date, known as a statute of limitations. Please call right away to ensure that you do not waive your right to possible compensation.